The latest oncology news listed by date, covering all clinical focus areas, tumour types and more
FDA approves acalabrutinib with bendamustine and rituximab for previously untreated mantle cell lymphoma
On January 16, 2025, the Food and Drug Administration granted traditional approval to acalabrutinib with…